Latest News, Breaking News from Yemen
Removing barriers for newcomers and international students Calgary, March 20, 2023 (GLOBE NEWSWIRE) — Bow Valley College is announcing an exciting change to its admissions process for many international students and newcomers to Canada. Applicants from almost 50 countries around the world are now exempt from taking an English language proficiency test. “Bow Valley College prides […]
Removing barriers for newcomers and international students Calgary, March 20, 2023 (GLOBE NEWSWIRE) — Bow Valley College is announcing an exciting change to its admissions process for many international students and newcomers to Canada. Applicants from almost 50 countries around the world are now exempt from taking an English language proficiency test. “Bow Valley College prides […]
ALBANY, N.Y., March 17, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder contratual em pesquisa, desenvolvimento e fabricação, anunciou hoje que Philip Macnabb foi nomeado como Diretor Geral, sucedendo John Ratliff. “Em nome do Conselho de Administração, agradecemos John Ratliff pelo tremendo progresso que a Curia fez durante seu mandato”, disse Sean Cunningham, Diretor […]
ALBANY, N.Y., 18 mars 2023 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, développement et fabrication en sous-traitance de premier plan, a annoncé aujourd’hui que Philip Macnabb avait été nommé président-directeur général, succédant ainsi à John Ratliff. « Au nom du conseil d’administration, nous remercions John Ratliff pour les progrès prodigieux réalisés par Curia sous sa […]
Philip Macnabb ALBANY, N.Y., March 16, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Philip Macnabb has been appointed as chief executive officer, succeeding John Ratliff. “On behalf of the Board of Directors, we thank John Ratliff for the tremendous progress that Curia made during his tenure,” […]
Growing body of data supports Ampligen’s potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaks OCALA, Fla., March 16, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of […]